How Atea Pharmaceuticals, Inc. stacks up

AVIR · against 380 other Healthcare companies of similar size

Overall

36/ 100

Below the middle of the pack.

Ranked #259 of 381 · scores higher than 30% of peers

Bars: peers in each 10-point band of the overall score

72 peers with an overall score of 30–39, including AVIR · Click a bar to see the companies

The four scores behind it

Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)

Valuation#236 of 384Score 8 / 100 · beats 11%

Growth—Not enough reported data

Profitability#331 of 382Score 10 / 100 · beats 12%Risk#62 of 394Lower relative risk · safety 89 · beats 84%

Ranking by overall score

Top 5 and the companies ranked around AVIR

Rank	Company	Market cap	Overall	Valuation	Growth	Profitability	Risk
1	Arbutus Biopharma CorporationABUS · US-listed	595M USD	97	96	98	99	0 / 2
1	Q32 Bio Inc.QTTB · US-listed	261M USD	97	93	—	98	0 / 2
3	Zevra Therapeutics, Inc.ZVRA · US-listed	609M USD	91	95	99	99	0 / 2
4	Beijing Chunlizhengda Medical Instruments Co., Ltd.1858.HK · Hong Kong	2.9B HKD (≈$365M)	84	99	63	86	0 / 2
5	CorMedix Inc.CRMD · US-listed	433M USD	81	96	99	99	2 / 2
⋯
252	Orchid Pharma LimitedORCHPHARMA.NS · India	42.8B INR (≈$513M)	37	30	23	39	1 / 2
252	Alpha Teknova, Inc.TKNO · US-listed	394M USD	37	8	52	22	1 / 2
259	Zhuhai Rundu Pharmaceutical Co., Ltd.002923.SZ · China	3.0B CNY (≈$427M)	36	49	21	43	2 / 2
259	Artiva Biotherapeutics, Inc.ARTV · US-listed	205M USD	36	33	8	11	0 / 2
259	Atea Pharmaceuticals, Inc.AVIR · US-listed	334M USD	36	8	—	10	0 / 2
259	Eupraxia Pharmaceuticals Inc.EPRX · US-listed	455M USD	36	8	—	9	0 / 2
259	Fulgent Genetics, Inc.FLGT · US-listed	533M USD	36	8	32	25	0 / 2
259	Lineage Cell Therapeutics, Inc.LCTX · US-listed	255M USD	36	8	64	10	1 / 2
259	Principal Capital Public Company LimitedPRINC.BK · Southeast Asia	6.2B THB (≈$174M)	36	38	32	35	1 / 2

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…